0001127602-15-006771.txt : 20150219 0001127602-15-006771.hdr.sgml : 20150219 20150218164102 ACCESSION NUMBER: 0001127602-15-006771 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150217 FILED AS OF DATE: 20150218 DATE AS OF CHANGE: 20150218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Holtzman Steven H CENTRAL INDEX KEY: 0001300247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 15628560 MAIL ADDRESS: STREET 1: 115 POWERS ROAD CITY: SUDBURY STATE: MA ZIP: 01776 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-02-17 0000875045 BIOGEN IDEC INC. BIIB 0001300247 Holtzman Steven H BIOGEN IDEC INC. 225 BINNEY STREET CAMBRIDGE MA 02142 1 EVP Corporate Development Common Stock 2015-02-17 4 S 0 2128 389.11 D 4321 D Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Matthew S. Gilman, Attorney-in-Fact for Steven H. Holtzman 2015-02-18